Heimat platform architecture, full overview

Heimat platform architecture: 23 entries across 4 clusters (5 assets, 10 operational modules, 3 planned modules, 5 backbone capabilities).

Cluster 01 Assets (Strategic assets)

Strategic assets. 5 entries.

  • 01.01 Global pre-roll patent Status: asset. Internationally patented manufacturing technology for the industrial production of standardised pre-rolls. Key decisions: International filing instead of Swiss-only intellectual property; in-house manufacturing instead of licensing to third parties in core markets. Use cases: Proprietary-brand pre-rolls in retail and kiosk channels; licence and white label manufacturing for partners.
  • 01.02 Swiss Made manufacturing site Status: asset. Near-GMP Swiss manufacturing as a regulatory and quality anchor of trust. Key decisions: Swiss location instead of nearshoring; investment in own facilities instead of contract manufacturing. Use cases: Provenance promise for retail and pharmacy; basis for export into regulated markets.
  • 01.03 Regulatory authorisations Status: asset. Existing authorisations as market access assets that new competitors cannot replicate in the short term. Key decisions: Ongoing maintenance instead of one-off applications; channel-specific authorisations (retail, pharmacy, pilot). Use cases: Rapid activation of new product lines; prerequisite for international expansion.
  • 01.04 Regulatory infrastructure Status: asset. Internal processes, documentation and regulatory contacts as reusable capital of the platform. Key decisions: In-house regulatory affairs instead of full outsourcing; standardised dossiers for multiple modules. Use cases: Accelerated launches of new modules; basis for regulatory pilot programmes.
  • 01.05 Formulations & IP Status: asset. Portfolio of proprietary formulations for different channels and effect profiles. Key decisions: In-house R&D instead of pure sourcing; modular formulation toolkit for scaling. Use cases: Differentiation in retail; basis for medical applications.

Cluster 02 Operative modules (Active in the market today)

Active in the market today. 10 entries.

  • 02.01 Heimat proprietary brand Status: operational. Proprietary Swiss platform brand for the development, marketing and scaling of regulated products. Key decisions: Building a single umbrella brand instead of multi-brand fragmentation; full control over positioning and margins. Use cases: Premium segment in retail; recognisable anchor across channels.
  • 02.02 Heimat Original proprietary brand Status: operational. Standalone product line to open up additional market segments. Key decisions: Separate line for volume and access strategies; deliberate distinction from the premium umbrella brand. Use cases: Listing of new channels; testing ground for product and pricing strategies.
  • 02.03 Retail Switzerland Status: operational. Nationwide Swiss distribution infrastructure via established trade, convenience and specialist retail channels. Key decisions: Direct trade relationships instead of pure distributor models; channel-specific assortments instead of a uniform offering. Use cases: Mass reach for proprietary brands; platform for product innovations.
  • 02.04 E-commerce Switzerland Status: operational. Digital distribution infrastructure via proprietary online channels and established e-commerce platforms. Key decisions: Combination of D2C and marketplace instead of single channel; data ownership through proprietary storefronts. Use cases: Direct sales and customer data; scaling without shelf-space limits.
  • 02.05 Tobacconist network Austria Status: operational. Regulatorily integrated access to the Austrian tobacconist system. Key decisions: Market entry via an established regulated system; local assortments instead of a Swiss copy-paste approach. Use cases: Entry into the Austrian retail market; blueprint for further EU markets.
  • 02.06 Pharmacies Switzerland Status: operational. Structural access to the Swiss pharmacy market via established pharmaceutical wholesale networks. Key decisions: Wholesale route instead of direct sales to individual pharmacies; healthcare channel managed separately from retail. Use cases: Advice-intensive products; basis for medical extensions.
  • 02.07 White Label Status: operational. Development and manufacturing of regulatory-compliant products within the Swiss value chain. Key decisions: Facility utilisation via partners instead of idle capacity; IP protection for partner formulations. Use cases: Revenue lever alongside proprietary brands; door opener to new markets.
  • 02.08 Heimat Hub Status: operational. Proprietary vending infrastructure for the distribution of regulated products. Key decisions: In-house operation instead of third-party vending; modular rollout at high-traffic locations. Use cases: 24/7 availability in the retail environment; data points on demand by location.
  • 02.09 State THC pilot programme WIIID Status: operational. Participation in Switzerland's state-approved THC pilot programme. Key decisions: Active authority partnership instead of waiting; data collection as a basis for regulation. Use cases: Regulatory learning curve; positioning for future full-market regulation.
  • 02.10 Research & studies Status: operational. Collaborations with scientific institutions to develop new applications and evidence. Key decisions: Peer-reviewed publications instead of pure marketing claims; long-term partnerships with clinics. Use cases: Scientific anchor of trust; basis for medical authorisations.

Cluster 03 Future (Planned extensions)

Planned extensions. 3 entries.

  • 03.01 THC formulations Status: planned. Development of standardised cannabinoid-based formulations for medical applications. Key decisions: Focus on standardised, reproducible formulations; development in parallel with regulatory opening. Use cases: Medical prescription; clinical studies and care.
  • 03.02 Clinics & hospitals Status: planned. Integration of clinical institutions and medical care partners. Key decisions: Institutional partnerships instead of individual physicians; built together with the research module. Use cases: Clinical care; study and real-world data.
  • 03.03 Telemedicine & e-prescription Status: planned. Digital infrastructure for advice, prescription and patient care. Key decisions: Digital-first supply pathway; connection to the pharmacy and clinic modules. Use cases: Low-threshold access for patients; scalable care without geographic limits.

Cluster 04 Backbone (Foundation of the platform)

Foundation of the platform. 5 entries.

  • 04.01 Regulatory affairs Status: backbone. Cross-platform regulatory expertise for all modules and markets. Key decisions: Central regulatory team instead of module-local silos; early communication with authorities. Use cases: Secure launches; accelerated market entries.
  • 04.02 IP & patents Status: backbone. Continuous IP strategy to protect formulations, technologies and brands. Key decisions: Portfolio strategy instead of individual filings; international prioritisation by market relevance. Use cases: Protection of core products; leverage in partnerships.
  • 04.03 Market intelligence Status: backbone. Data foundation on channels, customers and competitors as a basis for management decisions. Key decisions: Proprietary data pipelines instead of panel-only data; reuse across all modules. Use cases: Assortment and pricing management; prioritisation of new modules.
  • 04.04 International expansion Status: backbone. Repeatable playbook for market entry into regulated foreign markets. Key decisions: Focus on regulated rather than grey markets; module replication instead of building anew per country. Use cases: Scaling of proven modules; country rollouts with a clear timeline.
  • 04.05 Research & development Status: backbone. R&D as a cross-functional capability for formulations, processes and new fields of application. Key decisions: Internal core competence plus external partnerships; pipeline thinking instead of individual projects. Use cases: Continuous product innovation; basis for medical extensions.
ARCHITECTURE

One platform.
With every module
more valuable.

A modular infrastructure that connects manufacturing, technology, regulatory affairs and market access into a scalable platform.

01 Platform logic

Four clusters. One integrated system.

BACKBONE
Connects all modules
ASSETS
Protect platform value
OPERATIONAL MODULES
Create market access
FUTURE
Extend the platform
Backbone

Regulatory affairs, technology and standards for all modules.

Assets

Strategic assets with durable company value.

Operative modules

Active infrastructure modules with direct market access.

Future

Planned extensions for new healthcare markets.

02 Four clusters

Each cluster fulfils its own function. Together, they form a platform.

Backbone

Regulatory, technological and organisational foundations that connect all modules and make them scalable.

  • Compliance & quality management
  • IT & data infrastructure
  • Operating processes & standards
Assets

Long-term, hard-to-replicate assets with durable company value.

  • Patents & intellectual property
  • Licences & authorisations
  • Manufacturing & logistics sites
Operative modules

Modules active today that connect the platform directly with markets and customers.

  • Retail & distribution
  • Pharmacy network
  • White Label
  • Austria
Future

New healthcare markets that systematically expand the platform and unlock new revenue potential.

  • Medical Cannabis
  • Telemedicine
  • Clinical care
Guiding principle
"Every new module increases the value of the entire platform."
03 Modules

Platform modules at a glance.

Active
In development
C.01

Distribution

4 Modules
  1. Retail module
    Active
    Description

    Nationwide Swiss distribution infrastructure via established trade, convenience and specialist retail channels.

    Platform contribution

    Enables the scaling of further products, brands and infrastructure modules across existing distribution channels.

  2. E-commerce module
    Active
    Description

    Digital distribution infrastructure via proprietary online channels and established e-commerce platforms.

    Platform contribution

    Integrates digital market access into stationary distribution and scales reach.

  3. Tobacconist module Austria
    Active
    Description

    Regulatorily integrated access to the Austrian tobacconist system.

    Platform contribution

    Opens up a state-regulated distribution channel and extends the platform beyond Switzerland for the first time.

  4. Heimat Hub
    Active
    Description

    Proprietary vending infrastructure for the distribution of regulated products.

    Platform contribution

    Creates an additional direct distribution channel with high operational flexibility.

C.02

Manufacturing & IP

2 Modules
  1. White-label module
    Active
    Description

    Development and manufacturing of regulatory-compliant products within the Swiss value chain.

    Platform contribution

    Integrates development, manufacturing and packaging into an end-to-end infrastructure for partner products.

  2. Global pre-roll patent
    Active
    Description

    Internationally patented manufacturing technology for the industrial production of standardised pre-rolls.

    Platform contribution

    Protects the platform's technological uniqueness and raises its barriers to entry.

C.03

Healthcare

5 Modules
  1. Pharmacy module
    Active
    Description

    Structural access to the Swiss pharmacy market via established pharmaceutical wholesale networks.

    Platform contribution

    Opens access to the Swiss healthcare market and integrates pharmaceutical applications.

  2. WIIID module
    In development
    Description

    Participation in Switzerland's state-approved THC pilot programme.

    Platform contribution

    Extends regulatory expertise and operational experience in the controlled cannabis market.

  3. Telemedicine & e-prescription
    In development
    Description

    Digital infrastructure for advice, prescription and patient care.

    Platform contribution

    Integrates digital supply chains and new healthcare processes into the platform.

  4. Clinics & hospitals
    In development
    Description

    Integration of clinical institutions and medical care partners.

    Platform contribution

    Connects the platform with institutional healthcare structures and clinical networks.

  5. THC formulations
    In development
    Description

    Development of standardised cannabinoid-based formulations for medical applications.

    Platform contribution

    Enables future medical cannabis products and pharmaceutical applications.

C.04

Brand & research

3 Modules
  1. Heimat proprietary brand
    Active
    Description

    Proprietary Swiss platform brand for the development, marketing and scaling of regulated products.

    Platform contribution

    Validates new products, unlocks new markets and strengthens the entire platform.

  2. Heimat Original proprietary brand
    Active
    Description

    Standalone product line to open up additional market segments.

    Platform contribution

    Enables the testing of new product concepts and accelerates the expansion of further platform modules.

  3. Research & studies
    Active
    Description

    Collaborations with scientific institutions to develop new applications and evidence.

    Platform contribution

    Strengthens scientific credibility and accelerates the long-term development of the platform.

04 Platform effect

With every new module, the platform becomes more valuable.

Platform effect: four-stage cycle

The platform effect of Heimat Manufaktur is a self-reinforcing cycle of four steps. Each new module increases the value of the existing platform.

  1. Step 01 New modules: expand capabilities.
  2. Step 02 Market access: unlocks new markets.
  3. Step 03 Economies of scale: strengthen existing modules.
  4. Step 04 New capabilities: enable further growth.
  5. The cycle closes: new capabilities in turn enable new modules.
Contact

Let's talk aboutCollaboration.

Whether market access, manufacturing, white label, technology or strategic partnership: speak with our team about joint projects in regulated markets.

Partnershipsinfo@heimatmanufaktur.ch
HeadquartersSteinach, Switzerland

This website serves exclusively as corporate information. No specific medical content, product offers or health claims are communicated.